Dissonant health transition in the states of Mexico, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

The Lancet

Volumn 388, Issue 10058, 2016, Pages 2386-2402

  Gómez Dantés, Héctor ^a   Fullman, Nancy ^b   Lamadrid Figueroa, Héctor ^a   Cahuana Hurtado, Lucero ^a   Darney, Blair ^a   Avila Burgos, Leticia ^a   Correa Rotter, Ricardo ^c   Rivera, Juan A ^a   Barquera, Simon ^a   González Pier, Eduardo ^d   Aburto Soto, Tania ^a   de Castro, Elga Filipa Amorin ^a   Barrientos Gutiérrez, Tonatiuh ^a   Basto Abreu, Ana C ^a   Batis, Carolina ^a   Borges, Guilherme ^f   Campos Nonato, Ismael ^a   Campuzano Rincón, Julio C ^a   de Jesús Cantoral Preciado, Alejandra ^a   Contreras Manzano, Alejandra G ^a   Cuevas Nasu, Lucia ^a   de la Cruz Gongora, Vanessa V ^a   Diaz Ortega, Jose L ^a   de Lourdes García García, María ^a   Garcia Guerra, Armando ^a   de Cossío, Teresita González ^g   González Castell, Luz D ^a   Heredia Pi, Ileana ^a   Hijar Medina, Marta C ^e   Jauregui, Alejandra ^a   Jimenez Corona, Aida ^a   Lopez Olmedo, Nancy ^a   Magis Rodríguez, Carlos ^e   Medina Garcia, Catalina ^a   Medina Mora, Maria E ^f   Mejia Rodriguez, Fabiola ^a   Montañez, Julio C ^a   Montero, Pablo ^a   Montoya, Alejandra ^a   Moreno Banda, Grea L ^a   Pedroza Tobías, Andrea ^a   Pérez Padilla, Rogelio ^h   Quezada, Amado D ^a   Richardson López Collada, Vesta L ⁱ   Riojas Rodríguez, Horacio ^a   Ríos Blancas, Maria J ^a   Razo Garcia, Christian ^a   Mendoza, Martha P Romero ^f   Sánchez Pimienta, Tania G ^a   Sánchez Romero, Luz M ^a   Schilmann, Astrid ^a   Servan Mori, Edson ^a   Shamah Levy, Teresa ^a   Téllez Rojo, Martha M ^a   Texcalac Sangrador, José L ^a   Wang, Haidong ^b   Vos, Theo ^b   Forouzanfar, Mohammad H ^b   Naghavi, Mohsen ^b   Lopez, Alan D ^j   Murray, Christopher J L ^b   Lozano, Rafael ^a,b   more..

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSITY OF WASHINGTON   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d Fundacion Mexicana para la Salud AC   (Mexico)

^e SECRETARÍA DE SALUD   (Mexico)

^f INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^g UNIVERSIDAD IBEROAMERICANA   (Mexico)

^h INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

ⁱ Academia Nacional de Medicina Me Xico   (Mexico)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COMMUNICABLE DISEASE; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIET RESTRICTION; DISABILITY ADJUSTED LIFE YEAR; DRUG USE; ENVIRONMENTAL FACTOR; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATISTICS; HEALTHY LIFE EXPECTANCY; HUMAN; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEXICO; MORTALITY RATE; NECK PAIN; NON COMMUNICABLE DISEASE; OCCUPATIONAL HAZARD; POPULATION DYNAMICS; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SOCIOECONOMICS; YEARS OF LIFE LOST; CHRONIC DISEASE; COMMUNICABLE DISEASES; DISABLED PERSON; GLOBAL DISEASE BURDEN; HEALTH; MORTALITY; STATISTICS AND NUMERICAL DATA; TRENDS;

CHRONIC DISEASE; COMMUNICABLE DISEASES; DISABLED PERSONS; FEMALE; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HEALTH TRANSITION; HUMANS; LIFE EXPECTANCY; MALE; MEXICO; MORTALITY; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84992092059     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31773-1     Document Type: Article

References (60)

1. 1 Wang, H, Liddell, CA, Coates, MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 957–979.
2. 2 Murray, CJL, Barber, RM, Foreman, KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386 (2015), 2145–2191.
3. 3 Stevens, G, Dias, RH, Thomas, KJA, et al. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med, 5, 2008, e125.
4. 4 Sepúlveda, J, Bustreo, F, Tapia, R, et al. Improvement of child survival in Mexico: the diagonal approach. Lancet 368 (2006), 2017–2027.
5. 5 Omran, AR, The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 49 (1971), 509–538.
6. 6 Salomon, JA, Murray, CJL, The epidemiologic transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev 28 (2002), 205–228.
7. 7 Santosa, A, Wall, S, Fottrell, E, Högberg, U, Byass, P, The development and experience of epidemiological transition theory over four decades: a systematic review. Glob Health Action, 7, 2014, 23574.
8. 8 Murray, CJL, Bobadilla, JL, Epidemiological transitions in the formerly socialist economies: divergent patterns of mortality and causes of death. Bobadilla, JL, Costello, CA, Mitchell, F, (eds.) Premature death in the new independent states, 1997, National Research Council (US) Committee on Population, Washington, DC.
9. 9 Rivera, JA, Barquera, S, Campirano, F, Campos, I, Safdie, M, Tovar, V, Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 5 (2002), 113–122.
10. 10 Lozano, R, Soliz, P, Gakidou, E, et al. Benchmarking of performance of Mexican states with effective coverage. Lancet 368 (2006), 1729–1741.
11. 11 Lozano, R, Gómez-Dantés, H, Garrido-Latorre, F, et al. La carga de enfermedad, lesiones, factores de riesgo y desafíos para el sistema de salud en México. Salud Publica Mex 55 (2013), 580–594.
12. 12 Frenk, J, Lozano, R, González-Block, MA, et al. Economía y salud: propuestas para el avance del sistema de salud en México. Informe final, 1994, Fundación Mexicana para la Salud, Mexico City.
13. 13 Frenk, J, Bridging the divide: global lessons from evidence-based health policy in Mexico. Lancet 368 (2006), 954–961.
14. 14 González-Pier, E, Gutiérrez-Delgado, C, Stevens, G, et al. Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet 368 (2006), 1608–1618.
15. 15 Lozano, R, Murray, CJL, Frenk, J, Bobadilla, J-L, Burden of disease assessment and health system reform: results of a study in Mexico. J Int Dev 7 (1995), 555–563.
16. 16 Frenk, J, González-Pier, E, Gómez-Dantés, O, Lezana, MA, Knaul, FM, Comprehensive reform to improve health system performance in Mexico. Lancet 368 (2006), 1524–1534.
17. 17 Aburto, JM, Beltrán-Sánchez, H, García-Guerrero, VM, Canudas-Romo, V, Homicides In Mexico reversed life expectancy gains for men and slowed them for women, 2000–10. Health Aff 35 (2016), 88–95.
18. 18 Secretaría de Salud. Estrategia Nacional para la Prevención y el Control del Sobrepeso, la Obesidad y la Diabetes, 2013, Secretaría de Salud, Mexico City.
19. 19 Barquera, S, Campos, I, Rivera, JA, Mexico attempts to tackle obesity: the process, results, push backs and future challenges. Obes Rev 14 (2013), 69–78.
20. 20 Gómez Dantés, H, Castro, V, Franco-Marina, F, et al. La carga de la enfermedad en países de América Latina. Salud Publica Mex 53:suppl 2 (2011), S72–S77.
21. 21 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
22. 22 Vos, T, Barber, RM, Bell, B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
23. 23 Forouzanfar, MH, Alexander, L, Anderson, HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 2287–2323.
24. 24 Consejo Nacional de Población (CONAPO). Índice de marginación por entidad federativa y municipio 2010, 2011, CONAPO, Mexico City http://www.conapo.gob.mx/en/CONAPO/Indices_de_Marginacion_2010_por_entidad_federativa_y_municipio (accessed Feb 17, 2016).
25. 25 Foreman, KJ, Lozano, R, Lopez, AD, Murray, CJ, Modeling causes of death: an integrated approach using CODEm. Popul Health Metr, 10, 2012, 1.
26. 26 Naghavi, M, Makela, S, Foreman, K, O'Brien, J, Pourmalek, F, Lozano, R, Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr, 8, 2010, 9.
27. 27 Salomon, JA, Haagsma, JA, Davis, A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 3 (2015), e712–e723.
28. 28 Kahn, K, Garenne, ML, Collinson, MA, Tollman, SM, Mortality trends in a new South Africa: hard to make a fresh start. Scand J Public Health Suppl 69 (2007), 26–34.
29. 29 Gutiérrez, G, Pérez-Cuevas, R, Levy, S, et al. Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México. BMC Public Health, 10, 2010, 417.
30. 30 Richardson, V, Sánchez-Uribe, E, Esparza-Aguilar, M, Esteves-Jaramillo, A, Suárez-Idueta, L, Contribution of Mexico's Universal Immunization Program to the Fourth Millennium Development Goal. Rev Panam Salud Publica 35 (2014), 248–255.
31. 31 Rivera, JA, Sotres-Alvarez, D, Habicht, J, Shamah, T, Villalpando, S, Impact of the Mexican program for education, health, and nutrition (PROGRESA) on rates of growth and anemia in infants and young children: a randomized effectiveness study. JAMA 291 (2004), 2563–2570.
32. 32 Hogan, MC, Saavedra-Avendano, B, Darney, BG, et al. Reclassifying causes of obstetric death in Mexico: a repeated cross-sectional study. Bull World Health Organ, 94, 2016, 362 69B.
33. 33 Tuomilehto, J, Lindström, J, Eriksson, JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001), 1343–1350.
34. 34 Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
35. 35 Obrador, GT, Villa, AR, Olvera, N, Gutiérrez, V, Contreras, D, Reyes, R, Longitudinal analysis of participants in the KEEP Mexico's chronic kidney disease screening program. Arch Med Res 44 (2013), 650–654.
36. 36 Wesseling, C, Crowe, J, Hogstedt, C, Jakobsson, K, Lucas, R, Wegman, DH, The epidemic of chronic kidney disease of unknown etiology in Mesoamerica: a call for interdisciplinary research and action. Am J Public Health 103 (2013), 1927–1930.
37. 37 Gutierrez-Padilla, JA, Mendoza-Garcia, M, Plascencia-Perez, S, et al. Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, Mexico. Am J Kidney Dis 55 (2010), 474–484.
38. 38 Levey, AS, Schoolwerth, AC, Burrows, NR, et al. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis 53 (2009), 522–535.
39. 39 Briceño-León, R, Villaveces, A, Concha-Eastman, A, Understanding the uneven distribution of the incidence of homicide in Latin America. Int J Epidemiol 37 (2008), 751–757.
40. 40 Heinle, K, Molzahn, C, Shirk, DA, Drug violence in Mexico: data analysis through 2014, 2015, Justice in Mexico, University of San Diego, San Diego, CA.
41. 41 Sánchez, ÁI, Villaveces, A, Krafty, RT, et al. Policies for alcohol restriction and their association with interpersonal violence: a time-series analysis of homicides in Cali, Colombia. Int J Epidemiol 40 (2011), 1037–1046.
42. 42 Gómez-Dantés, H, Lamadrid-Figueroa, H, Cahuana-Hurtado, L, et al. The burden of cancer in Mexico, 1990–2013. Salud Publica Mex 58 (2016), 118–131.
43. 43 Leal, YA, Fernández-Garrote, LM, Mohar-Betancourt, A, Meneses-García, A, The importance of registries in cancer control. Salud Publica Mex 58 (2016), 309–316.
44. 44 Jacob, KS, Depression: a major public health problem in need of a multi-sectoral response. Indian J Med Res 136 (2012), 537–539.
45. 45 Medina-Mora, ME, Borges, G, Lara, C, et al. Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 35 (2005), 1773–1783.
46. 46 Borges, G, Orozco, R, Benjet, C, Medina-Mora, ME, Suicidio y conductas suicidas en México: retrospectiva y situación actual. Salud Publica Mex 52 (2010), 292–304.
47. 47 Kovacs, FM, Abraira, V, Zamora, J, et al. Correlation between pain, disability, and quality of life in patients with common low back pain. Spine 29 (2004), 206–210.
48. 48 Reynales-Shigematsu, LM, El control del tabaco, estrategia esencial para reducir las enfermedades crónicas no transmisibles. Salud Publica Mex 54 (2012), 323–331.
49. 49 Thrasher, JF, Swayampakala, K, Arillo-Santillán, E, Sebrié, E, Walsemann, KM, Bottai, M, Impacto diferencial de la legislación federal y local de espacios libres de humo de tabaco en México: un estudio longitudinal entre fumadores adultos. Salud Publica Mex 52:suppl 2 (2010), S244–S253.
50. 50 Pérez-Núñez, R, Híjar, M, Celis, A, et al. Road traffic injuries in Mexico: evidence to strengthen the Mexican road safety strategy. Cad Saúde Pública 30 (2014), 911–925.
51. 51 Moodie, R, Stuckler, D, Monteiro, C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. Lancet 381 (2013), 670–679.
52. 52 Rivera, JA, Barquera, S, González-Cossío, T, Olaiz, G, Sepúlveda, J, Nutrition transition in Mexico and in other Latin American countries. Nutr Rev 62:suppl 2 (2004), S149–S157.
53. 53 Ng, M, Fleming, T, Robinson, M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
54. 54 Clark, SE, Hawkes, C, Murphy, SME, Hansen-Kuhn, KA, Wallinga, D, Exporting obesity: US farm and trade policy and the transformation of the Mexican consumer food environment. Int J Occup Environ Health 18 (2012), 53–65.
55. 55 Gracner, T, Bittersweet: how prices of sugar-rich foods contribute to the diet-related disease epidemic in Mexico, 2015, University of California, Berkeley, Berkeley, CA http://arefiles.ucdavis.edu/uploads/filer_public/2015/01/20/paper-3tgracner_0UHHUN9.pdf (accessed Feb 12, 2016).
56. 56 Colchero, MA, Popkin, BM, Rivera, JA, Ng, SW, Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ, 352, 2016, h6704.
57. 57 Cecchini, M, Sassi, F, Lauer, JA, Lee, YY, Guajardo-Barron, V, Chisholm, D, Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376 (2010), 1775–1784.
58. 58 Alianza por la Salud Alimentaria. Campaña 12 cucharadas. http://alianzasalud.org.mx/12cucharadas/ (accessed Aug 3, 2016).
59. 59 Barquera, S, Campos-Nonato, I, Rojas, R, Rivera, J, Obesidad en México: epidemiología y políticas de salud para su control y prevención. Gac Med Mex 146 (2010), 397–407.
60. 60 Murray, CJL, Dias, RH, Kulkarni, SC, Lozano, R, Stevens, GA, Ezzati, M, Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care 31 (2008), 451–458.